Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Thymosin β4 may boost hair growth by aiding stem cell movement and blood vessel formation.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

The enzyme PA-PLA1α is important for proper hair follicle development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

Alopecia areata incognito in children can be effectively treated with triamcinolone acetonide and supplements, leading to full hair regrowth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Telocytes in the scalp may help with skin regeneration and maintenance.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Some drugs used to treat inflammation may cause hair loss.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Researchers converted human embryonic stem cells into trophoblast stem cells using specific transcription factors.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

RTA 408 cream protects mice from radiation skin damage.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.